Update on antivirals.
D000225:Adenine / Q000008:administration & dosage / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001938:Brazil; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D004304:Dosage Forms; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage / Q000627:therapeutic use; D007262:Infusions, Intravenous; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D019258:Saquinavir / Q000008:administration & dosage / Q000627:therapeutic use*; D000068698:Tenofovir; D019562:Viral Load
D019380:Anti-HIV Agents; D004304:Dosage Forms; D017320:HIV Protease Inhibitors; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D019469:Indinavir; D000068698:Tenofovir; D000225:Adenine; D019258:Saquinavir